Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-10

Clinical Trial Update: Gent for Pharyngeal Gonorrhea (GC) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for Gent in pharyngeal gonorrhea; the study has been terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gent

Snippet

Sponsor: University of Washington | Conditions: Pharyngeal Gonococcal Infection | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2020-08-10